Matthew Paul Kowalsky

Insider Reports History

Location
Marblehead, MA
Signature
/s/ Matthew Paul Kowalsky
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Paul Kowalsky:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Chief Legal Officer Stock Option (right to buy) 90K 25 Nov 2025 Direct
Sigilon Therapeutics, Inc. CHIEF OF STAFF AND CLO Common Stock 0 11 Aug 2023 Direct
Sigilon Therapeutics, Inc. CHIEF OF STAFF AND CLO Stock Option (Right to Buy) 0 $0.75 11 Aug 2023 Direct

Insider Reports Filed by Matthew Paul Kowalsky

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENTA ENANTA PHARMACEUTICALS INC 25 Nov 2025 1 $0 4 Chief Legal Officer 26 Nov 2025, 17:08
ENTA ENANTA PHARMACEUTICALS INC 27 Nov 2024 1 $0 4 Chief Legal Officer 27 Nov 2024, 17:10
ENTA ENANTA PHARMACEUTICALS INC 29 Apr 2024 1 $0 4 Chief Legal Officer 01 May 2024, 16:27
ENTA ENANTA PHARMACEUTICALS INC 29 Apr 2024 0 $0 3 Chief Legal Officer 01 May 2024, 16:25
SGTX Sigilon Therapeutics, Inc. 11 Aug 2023 2 -$9.52K 4 CHIEF OF STAFF AND CLO 11 Aug 2023, 16:10
SGTX Sigilon Therapeutics, Inc. 28 Feb 2023 1 $0 4 CHIEF OF STAFF AND CLO 01 Mar 2023, 15:46
SGTX Sigilon Therapeutics, Inc. 28 Feb 2023 0 $0 3 CHIEF OF STAFF AND CLO 01 Mar 2023, 15:35